To assure cost credibility of the Medicare prescription drug benefit.
Medicare Drug Cost Credibility Act of 2005 - Provides that, if the net mandatory outlays for the Medicare prescription drug benefit for a fiscal year exceed the original Congressional Budget Office estimate of such benefit for that fiscal year, the Secretary of Health and Human Services shall utilize negotiating authority in order to reduce the acquisition cost for prescription drugs.
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line